17:27 EST Acelyrin (SLRN) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on SLRN: Acelyrin reports Q3 EPS (49c), consensus (80c) Is SLRN a Buy, Before Earnings? Acelyrin forms scientific, patient advisory board Acelyrin price target raised to $15 from $13 at Wells Fargo Acelyrin announces positive results from Phase 3 trial of izokibep